Basic information Safety Supplier Related

7-BROMO-3,4-DIHYDRO-2H-BENZO[B]OXEPIN-5-ONE

Basic information Safety Supplier Related

7-BROMO-3,4-DIHYDRO-2H-BENZO[B]OXEPIN-5-ONE Basic information

Product Name:
7-BROMO-3,4-DIHYDRO-2H-BENZO[B]OXEPIN-5-ONE
Synonyms:
  • 7-BROMO-3,4-DIHYDRO-2H-BENZO[B]OXEPIN-5-ONE
  • 7-BROMO-3,4-DIHYDROBENZO[B]OXEPIN-5(2H)-ONE
  • 7-BROMO-3,4-DIHYDRO-1-BENZOXEPIN-5(2H)-ONE
  • 7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)
  • 7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one 7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one
  • 7-bromo-3,4-dihydro-2h-1-benzoxepin-5-one
  • JR-8190, 7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one, 97%
  • 1-Benzoxepin-5(2H)-one, 7-bromo-3,4-dihydro-
CAS:
55580-08-0
MF:
C10H9BrO2
MW:
241.08
Mol File:
55580-08-0.mol
More
Less

7-BROMO-3,4-DIHYDRO-2H-BENZO[B]OXEPIN-5-ONE Chemical Properties

Boiling point:
104-109 °C(Press: 0.3 Torr)
Density 
1.528±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
More
Less

Safety Information

Risk Statements 
52
RIDADR 
UN 3082 9 / PGIII
WGK Germany 
3
More
Less

7-BROMO-3,4-DIHYDRO-2H-BENZO[B]OXEPIN-5-ONE Usage And Synthesis

Synthesis

1189816-63-4

55580-08-0

Step H2: 1-[5-Bromo-2-(2-bromoethoxy)phenyl]ethanone (9.0 g, 28.0 mmol) was dissolved in THF (175 mL) and cooled to 0 °C. Under stirring, sodium hydride (0.805 g, 33.5 mmol) was slowly added. The reaction mixture was carefully heated to reflux and maintained at reflux for 20 hours. Upon completion of the reaction, the mixture was cooled to room temperature and the reaction was quenched with 2 M HCl (50 mL). The mixture was transferred to a partition funnel and extracted by adding brine (300 mL) and EtOAc (250 mL). The organic layer was separated, dried with anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography with an eluent gradient of 10-30% EtOAc/hexane. The pure grades were collected and concentrated under reduced pressure to afford 7-bromo-3,4-dihydro-2H-benzo[B]oxepan-5-one (5.41 g, 22.4 mmol, 80% yield) as a colorless oil.LCMS (M + H)+ = 242.95.1H NMR (500 MHz, CDCl3) δ 7.91-7.85 (m, 1H), 7.54-7.48 (m, 1H), 7.91-7.85 (m, 1H). 7.54-7.48 (m, 1H), 6.98 (d, J = 8.5 Hz, 1H), 4.25 (t, J = 6.6 Hz, 2H), 2.91 (t, J = 6.9 Hz, 2H), 2.23 (quin, J = 6.8 Hz, 2H).

References

[1] Patent: WO2012/162330, 2012, A1. Location in patent: Page/Page column 41-42
[2] Patent: US2009/247567, 2009, A1. Location in patent: Page/Page column 183
[3] Patent: US2011/76291, 2011, A1. Location in patent: Page/Page column 144-145
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 2, p. 627 - 640

7-BROMO-3,4-DIHYDRO-2H-BENZO[B]OXEPIN-5-ONESupplier

Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Tianjin Englon Technology Co., LTD
Tel
010-010-1234567 17526513758
Email
2062435649@qq.com
LABTER PHARMATECH(BEIJING) CO.,LTD
Tel
010-56330744 18310155299
Email
sales@labter.com.cn
TaiChem Taizhou Limited
Tel
052386810091
Email
zcwy9518@yeah.net
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com